{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:10:22Z","timestamp":1791515422888,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.coph.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T14:53:34Z","timestamp":1522767214000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Intra-articular drug delivery systems for joint diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Muhammad Farooq","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine TN","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.03.013_bib0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.berh.2014.08.002","article-title":"Burden of disability due to musculoskeletal (MSK) disorders","volume":"28","author":"March","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.coph.2018.03.013_bib0260","doi-asserted-by":"crossref","first-page":"45223","DOI":"10.1038\/srep45223","article-title":"Post-traumatic osteoarthritis in mice following mechanical injury to the synovial joint","volume":"7","author":"Rai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2018.03.013_bib0265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jor.23413","article-title":"Early changes in the knee of healer and non-healer mice following non-invasive mechanical injury","volume":"35","author":"Duan","year":"2017","journal-title":"J Orthop Res"},{"key":"10.1016\/j.coph.2018.03.013_bib0270","article-title":"Transcriptome comparison of meniscus from patients with and without osteoarthritis","author":"Brophy","year":"2017","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.coph.2018.03.013_bib0275","doi-asserted-by":"crossref","first-page":"e0155373","DOI":"10.1371\/journal.pone.0155373","article-title":"RNA microarray analysis of macroscopically normal articular cartilage from knees undergoing partial medial meniscectomy: potential prediction of the risk for developing osteoarthritis","volume":"11","author":"Rai","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2018.03.013_bib0280","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1177\/0363546507307396","article-title":"The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis","volume":"35","author":"Lohmander","year":"2007","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.coph.2018.03.013_bib0285","doi-asserted-by":"crossref","first-page":"e104681","DOI":"10.1371\/journal.pone.0104681","article-title":"Cruciate ligament reconstruction and risk of knee osteoarthritis: the association between cruciate ligament injury and post-traumatic osteoarthritis. a population based nationwide study in Sweden, 1987\u20132009","volume":"9","author":"Nordenvall","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2018.03.013_bib0290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0000000000000478","article-title":"Exercise in the management of knee and hip osteoarthritis","volume":"30","author":"Wellsandt","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coph.2018.03.013_bib0295","article-title":"Osteoarthritis: the genesis of pain","author":"Fu","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.coph.2018.03.013_bib0300","first-page":"CD005328","article-title":"Intra-articular corticosteroid for knee osteoarthritis","author":"Juni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2018.03.013_bib0305","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.rehab.2016.02.008","article-title":"Evidence and recommendations for use of intra-articular injections for knee osteoarthritis","volume":"59","author":"Nguyen","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.coph.2018.03.013_bib0310","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.290.23.3115","article-title":"Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis","volume":"290","author":"Lo","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2018.03.013_bib0315","series-title":"Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee","author":"Newberry","year":"2015"},{"key":"10.1016\/j.coph.2018.03.013_bib0320","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.2174\/0929867323666160530144445","article-title":"Nanomedicine for intra-articular drug delivery in rheumatoid arthritis","volume":"23","author":"O\u2019Mary","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.coph.2018.03.013_bib0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2017.09.005","article-title":"Polymeric micelles: basic research to clinical practice","volume":"532","author":"Deshmukh","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2018.03.013_bib0330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2016.12.019","article-title":"Polymeric mixed micelles as nanomedicines: achievements and perspectives","volume":"113","author":"Cagel","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.coph.2018.03.013_bib0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13346-015-0234-2","article-title":"Particle-based technologies for osteoarthritis detection and therapy","volume":"6","author":"Kavanaugh","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.coph.2018.03.013_bib0340","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jsps.2017.04.001","article-title":"Toxicity evaluation of methoxy poly(ethylene oxide)-block-poly(epsilon-caprolactone) polymeric micelles following multiple oral and intraperitoneal administration to rats","volume":"25","author":"Binkhathlan","year":"2017","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.coph.2018.03.013_bib0345","doi-asserted-by":"crossref","first-page":"025019","DOI":"10.1088\/1758-5090\/aa703c","article-title":"Design of electrohydrodynamic sprayed polyethylene glycol hydrogel microspheres for cell encapsulation","volume":"9","author":"Qayyum","year":"2017","journal-title":"Biofabrication"},{"key":"10.1016\/j.coph.2018.03.013_bib0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.colsurfb.2017.03.003","article-title":"An overview of hydrogel-based intra-articular drug delivery for the treatment of osteoarthritis","volume":"154","author":"He","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.coph.2018.03.013_sbref0355","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/ten.tea.2016.0524","article-title":"Hyaluronic acid hydrogel functionalized with self-assembled micelles of amphiphilic pegylated kartogenin for the treatment of osteoarthritis","volume":"23","author":"Kang","year":"2017","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.coph.2018.03.013_bib0360","doi-asserted-by":"crossref","first-page":"124","DOI":"10.22203\/eCM.v029a10","article-title":"Sustained intra-articular delivery of IL-1RA from a thermally responsive elastin-like polypeptide as a therapy for post-traumatic arthritis","volume":"29","author":"Kimmerling","year":"2015","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.coph.2018.03.013_bib0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrrheum.2016.210","article-title":"Cartilage-targeting drug delivery: can electrostatic interactions help?","volume":"13","author":"Bajpayee","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coph.2018.03.013_sbref0370","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2106\/JBJS.N.00918","article-title":"An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial","volume":"97","author":"Bodick","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.coph.2018.03.013_bib0375","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.5435\/JAAOS-D-15-00339","article-title":"Emerging concepts in gene therapy for osteoarthritis","volume":"23","author":"Rai","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.coph.2018.03.013_sbref0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/hum.2017.181","article-title":"Gene delivery to joints by intra-articular injection","volume":"29","author":"Evans","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coph.2018.03.013_bib0385","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.1038\/mtm.2016.8","article-title":"Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes","volume":"3","author":"Ruan","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.coph.2018.03.013_sbref0390","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1038\/mtm.2015.52","article-title":"Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.coph.2018.03.013_sbref0395","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.5435\/JAAOS-D-17-00695","article-title":"Arthritis gene therapy approved in Korea","volume":"26","author":"Evans","year":"2018","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.coph.2018.03.013_bib0400","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nano.2015.09.013","article-title":"Nanodrugs to target articular cartilage: an emerging platform for osteoarthritis therapy","volume":"12","author":"Bottini","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.coph.2018.03.013_bib0405","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/gt.2016.33","article-title":"Tackling chondrocyte hypertrophy with multifunctional nanoparticles","volume":"23","author":"Bottini","year":"2016","journal-title":"Gene Ther"},{"key":"10.1016\/j.coph.2018.03.013_bib0410","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-017-2531-z","article-title":"Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair","author":"Lolli","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.coph.2018.03.013_sbref0415","doi-asserted-by":"crossref","first-page":"E6199","DOI":"10.1073\/pnas.1608245113","article-title":"Suppression of NF-kappaB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury","volume":"113","author":"Yan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2018.03.013_bib0420","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gt.2015.16","article-title":"Intra-articular delivery of anti-Hif-2alpha siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice","volume":"22","author":"Pi","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/j.coph.2018.03.013_bib0425","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10753-017-0534-4","article-title":"Adenovirus-mediated small interfering RNA targeting TAK1 ameliorates joint inflammation with collagen-induced arthritis in mice","volume":"40","author":"Luo","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.coph.2018.03.013_bib0430","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00441-016-2563-y","article-title":"Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice","volume":"368","author":"Hoshi","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.coph.2018.03.013_bib0435","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2018.03.013_bib0440","doi-asserted-by":"crossref","first-page":"978351","DOI":"10.1155\/2014\/978351","article-title":"Application of liposomes in treatment of rheumatoid arthritis: quo vadis","volume":"2014","author":"Kapoor","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.coph.2018.03.013_bib0445","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.39446","article-title":"Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of MicroRNAs 140-3p and 140-5p","volume":"68","author":"Peng","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coph.2018.03.013_bib0450","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ymthe.2016.12.020","article-title":"Intra-articular delivery of Antago-miR-483-5p inhibits osteoarthritis by modulating Matrilin 3 and tissue inhibitor of metalloproteinase 2","volume":"25","author":"Wang","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.coph.2018.03.013_bib0455","doi-asserted-by":"crossref","first-page":"e3140","DOI":"10.1038\/cddis.2017.522","article-title":"MicroRNA-145 attenuates TNF-alpha-driven cartilage matrix degradation in osteoarthritis via direct suppression of MKK4","volume":"8","author":"Hu","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coph.2018.03.013_bib0460","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/mt.2012.131","article-title":"IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis","volume":"21","author":"Garaulet","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.coph.2018.03.013_bib0465","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.23598","article-title":"Application of inflammation-responsive promoter for an in vitro arthritis model","volume":"58","author":"Rachakonda","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coph.2018.03.013_sbref0470","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","article-title":"Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs","volume":"8","author":"Brunger","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.coph.2018.03.013_bib0475","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molmed.2017.08.002","article-title":"Genome engineering for personalized arthritis therapeutics","volume":"23","author":"Adkar","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coph.2018.03.013_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21060","article-title":"Autologous chondrocyte implantation in the knee: systematic review and economic evaluation","volume":"21","author":"Mistry","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.coph.2018.03.013_bib0485","first-page":"168","article-title":"The healing effect of bone marrow-derived stem cells in knee osteoarthritis: a case report","volume":"5","author":"Mehrabani","year":"2016","journal-title":"World J Plast Surg"},{"key":"10.1016\/j.coph.2018.03.013_bib0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1756-185X.12670","article-title":"Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients","volume":"19","author":"Davatchi","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.coph.2018.03.013_bib0495","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e32835aa28d","article-title":"Stem cell-based therapies for osteoarthritis: challenges and opportunities","volume":"25","author":"Diekman","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coph.2018.03.013_sbref0500","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.stem.2018.01.014","article-title":"Engineering stem and stromal cell therapies for musculoskeletal tissue repair","volume":"22","author":"Loebel","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:48:35Z","timestamp":1761461315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217301431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":50,"alternative-id":["S1471489217301431"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.03.013","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-articular drug delivery systems for joint diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}